Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 111

1.

Sequence variation analysis of the E2 gene of human papilloma virus type 16 in cervical lesions from women in Greece.

Tsakogiannis D, Ruether I, Kyriakopoulou Z, Pliaka V, Theoharopoulou A, Skordas V, Panotopoulou E, Nepka C, Markoulatos P.

Arch Virol. 2012 May;157(5):825-32. doi: 10.1007/s00705-012-1236-8.

PMID:
22294445
2.

Viral DNA load, physical status and E2/E6 ratio as markers to grade HPV16 positive women for high-grade cervical lesions.

Cricca M, Morselli-Labate AM, Venturoli S, Ambretti S, Gentilomi GA, Gallinella G, Costa S, Musiani M, Zerbini M.

Gynecol Oncol. 2007 Sep;106(3):549-57. Epub 2007 Jun 13.

PMID:
17568661
3.

Human papillomavirus 16 E6/E7 transcript and E2 gene status in patients with cervical neoplasia.

Sathish N, Abraham P, Peedicayil A, Sridharan G, John S, Chandy G.

Mol Diagn. 2004;8(1):57-64.

PMID:
15230643
4.

Nucleotide polymorphisms of the human papillomavirus 16 E1 gene.

Tsakogiannis D, Darmis F, Gortsilas P, Ruether IG, Kyriakopoulou Z, Dimitriou TG, Amoutzias G, Markoulatos P.

Arch Virol. 2014 Jan;159(1):51-63. doi: 10.1007/s00705-013-1790-8. Epub 2013 Jul 24.

PMID:
23881083
5.

[Human papillomavirus type 16 intratypic variant infection and risk for cervical neoplasia].

Hao M, Wang XL, Bian ML, Liu HT.

Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2010 Feb;24(1):24-6. Chinese.

PMID:
20848842
6.

Genetic and epigenetic changes of HPV16 in cervical cancer differentially regulate E6/E7 expression and associate with disease progression.

Mazumder Indra D, Singh RK, Mitra S, Dutta S, Chakraborty C, Basu PS, Mondal RK, Roychoudhury S, Panda CK.

Gynecol Oncol. 2011 Dec;123(3):597-604. doi: 10.1016/j.ygyno.2011.08.004. Epub 2011 Sep 10.

PMID:
21911249
7.

Molecular and phylogenetic analysis of the HPV 16 E4 gene in cervical lesions from women in Greece.

Tsakogiannis D, Ruether IG, Kyriakopoulou Z, Pliaka V, Skordas V, Gartzonika C, Levidiotou-Stefanou S, Markoulatos P.

Arch Virol. 2012 Sep;157(9):1729-39. doi: 10.1007/s00705-012-1356-1. Epub 2012 Jun 9.

PMID:
22684534
8.

Prevalence of human papillomavirus type 16 and its variants in abnormal squamous cervical cells in Northeast Thailand.

Chopjitt P, Ekalaksananan T, Pientong C, Kongyingyoes B, Kleebkaow P, Charoensri N.

Int J Infect Dis. 2009 Mar;13(2):212-9. doi: 10.1016/j.ijid.2008.06.017. Epub 2008 Oct 5.

9.

Influence of human papillomavirus type 16 (HPV-16) E2 polymorphism on quantification of HPV-16 episomal and integrated DNA in cervicovaginal lavages from women with cervical intraepithelial neoplasia.

Azizi N, Brazete J, Hankins C, Money D, Fontaine J, Koushik A, Rachlis A, Pourreaux K, Ferenczy A, Franco E, Coutlée F; Canadian Women's HIV Study Group..

J Gen Virol. 2008 Jul;89(Pt 7):1716-28. doi: 10.1099/vir.0.83579-0.

PMID:
18559943
10.

HPV16 E2 is an immediate early marker of viral infection, preceding E7 expression in precursor structures of cervical carcinoma.

Xue Y, Bellanger S, Zhang W, Lim D, Low J, Lunny D, Thierry F.

Cancer Res. 2010 Jul 1;70(13):5316-25. doi: 10.1158/0008-5472.CAN-09-3789. Epub 2010 Jun 8.

11.

Human papillomavirus 16 load and E2/E6 ratio in HPV16-positive women: biomarkers for cervical intraepithelial neoplasia >or=2 in a liquid-based cytology setting?

Boulet GA, Benoy IH, Depuydt CE, Horvath CA, Aerts M, Hens N, Vereecken AJ, Bogers JJ.

Cancer Epidemiol Biomarkers Prev. 2009 Nov;18(11):2992-9. doi: 10.1158/1055-9965.EPI-09-0025. Epub 2009 Oct 27.

12.

Molecular and evolutionary analysis of HPV16 E6 and E7 genes in Greek women.

Tsakogiannis D, Papadopoulou A, Kontostathi G, Ruether IG, Kyriakopoulou Z, Dimitriou TG, Orfanoudakis G, Markoulatos P.

J Med Microbiol. 2013 Nov;62(Pt 11):1688-96. doi: 10.1099/jmm.0.055491-0. Epub 2013 Aug 14.

PMID:
23946477
13.

[Detection of E2 gene polymorphism of human papillomavirus type 16 in patients with cervical lesions and cervical cancer].

Qiu F, Yuan L, Huang X.

Nan Fang Yi Ke Da Xue Xue Bao. 2012 Oct;32(10):1503-6. Chinese.

14.

Physical status of the E2 human papilloma virus 16 viral gene in cervical preneoplastic and neoplastic lesions.

Tonon SA, Picconi MA, Bos PD, Zinovich JB, Galuppo J, Alonio LV, Teyssie AR.

J Clin Virol. 2001 May;21(2):129-34.

PMID:
11378493
15.

Sites of disruption within E1 and E2 genes of HPV16 and association with cervical dysplasia.

Tsakogiannis D, Gortsilas P, Kyriakopoulou Z, Ruether IG, Dimitriou TG, Orfanoudakis G, Markoulatos P.

J Med Virol. 2015 Nov;87(11):1973-80. doi: 10.1002/jmv.24256. Epub 2015 May 19.

PMID:
25959607
16.

Human papillomavirus type 16 E2 and E6/E7 variants.

Swan DC, Rajeevan M, Tortolero-Luna G, Follen M, Tucker RA, Unger ER.

Gynecol Oncol. 2005 Mar;96(3):695-700.

PMID:
15721413
17.

Variation in the E2-binding domain of HPV 16 is associated with high-grade squamous intraepithelial lesions of the cervix.

Giannoudis A, Duin M, Snijders PJ, Herrington CS.

Br J Cancer. 2001 Apr 20;84(8):1058-63.

18.

Molecular variants of human papilloma virus 16 E2, E4, E5, E6 and E7 genes associated with cervical neoplasia in Romanian patients.

Plesa A, Anton G, Iancu IV, Diaconu CC, Huica I, Stanescu AD, Socolov D, Nistor E, Popa E, Stoian M, Botezatu A.

Arch Virol. 2014 Dec;159(12):3305-20. doi: 10.1007/s00705-014-2199-8. Epub 2014 Aug 21.

PMID:
25143263
19.

HPV prevalence, E6 sequence variation and physical state of HPV16 isolates from patients with cervical cancer in Sichuan, China.

Qiu AD, Wu EQ, Yu XH, Jiang CL, Jin YH, Wu YG, Chen Y, Chen Y, Shan YM, Zhang GN, Fan Y, Zha X, Kong W.

Gynecol Oncol. 2007 Jan;104(1):77-85. Epub 2006 Sep 12.

PMID:
16970982
20.

[Analysis on the expression of human papillomavirus type 16 E2 and E6 oncogenes and disruption of E2 in cervical cancer].

Wang JT, Ding L, Gao ES, Cheng YY.

Zhonghua Liu Xing Bing Xue Za Zhi. 2007 Oct;28(10):968-71. Chinese.

PMID:
18399141

Supplemental Content

Support Center